Pre-Operative Sterilization Study of Levofloxacin Ophthalmic Solution 1.5%
- Conditions
- Diseases necessary for intraocular Surgery
- Registration Number
- JPRN-UMIN000007622
- Lead Sponsor
- Miyata eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1.Patients with history of hypersensitivity or severe adverse effects on newquinolone antibiotics 2.Patients suspecting bacterium, fungus or virus infection 3.Patients administered antibiotics or immunosuppressants within 3 months prior to the study 4.Patients hospitalized other than ocular surgeries 5.Patients with uncontrollable underlying disorders or complications 6.Pregnant or breast-feeding women 7.Patients wearing contact lenses during the study 8.Patients having history of ocular surgery within 3 months prior to the study on the study eye 9. Patients whom investigators estimate are not eligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pre-Operative bacterial eradication rate of Levofloxacin Ophthalmic Solution 1.5%
- Secondary Outcome Measures
Name Time Method